| Extracellular vesicles: exosomes, microparticles, their parts, and their targets to enable their biomanufacturing and clinical applications CY Kao, ET Papoutsakis Current opinion in biotechnology 60, 89-98, 2019 | 147 | 2019 |
| How do megakaryocytic microparticles target and deliver cargo to alter the fate of hematopoietic stem cells? J Jiang, CY Kao, ET Papoutsakis Journal of Controlled Release 247, 1-18, 2017 | 71 | 2017 |
| Engineering human megakaryocytic microparticles for targeted delivery of nucleic acids to hematopoietic stem and progenitor cells CY Kao, ET Papoutsakis Science advances 4 (11), eaau6762, 2018 | 44 | 2018 |
| Human megakaryocytic microparticles induce de novo platelet biogenesis in a wild-type murine model C Escobar, CY Kao, S Das, ET Papoutsakis Blood Advances 4 (5), 804-814, 2020 | 24 | 2020 |
| Role of p53 and transcription-independent p53-induced apoptosis in shear-stimulated megakaryocytic maturation, particle generation, and platelet biogenesis SA Luff, CY Kao, ET Papoutsakis PLoS One 13 (9), e0203991, 2018 | 19 | 2018 |
| miR-486-5p and miR-22-3p enable megakaryocytic differentiation of hematopoietic stem and progenitor cells without thrombopoietin CY Kao, J Jiang, W Thompson, ET Papoutsakis International journal of molecular sciences 23 (10), 5355, 2022 | 11 | 2022 |
| Aggregation behavior of casein is correlated with the type of glycation-inducing agent WL Chou, LTW Lin, YY Shih, CT Li, CY Kao, WB Tsai, SSS Wang Journal of the Taiwan Institute of Chemical Engineers 45 (2), 393-403, 2014 | 8 | 2014 |
| Human γD-crystallin aggregation induced by ultraviolet C irradiation is suppressed by resveratrol JWR Wu, CY Kao, LTW Lin, WS Wen, JT Lai, SSS Wang Biochemical engineering journal 78, 189-197, 2013 | 7 | 2013 |
| Megakaryocyte membrane‐wrapped nanoparticles for targeted cargo delivery to hematopoietic stem and progenitor cells S Das, JC Harris, EJ Winter, CY Kao, ES Day, ET Papoutsakis Bioengineering & Translational Medicine 8 (3), e10456, 2023 | 4 | 2023 |
| Role of Cytokines and Growth Factors in the Manufacturing of iPSC-Derived Allogeneic Cell Therapy Products CY Kao, JA Mills, CJ Burke, B Morse, BF Marques Biology 12 (5), 677, 2023 | 3 | 2023 |
| Examining the inhibitory actions of copolypeptides against amyloid fibrillogenesis of bovine insulin CY Kao, JK Lai, TH Lin, YJ Lin, JS Jan, SSS Wang Biochemical engineering journal 78, 181-188, 2013 | 2 | 2013 |
| Biomembrane-covered nanoparticles (bionps) for delivering active agents to stem cells ET Papoutsakis, E Day, E Winter, J Harris, CY Kao, S Das US Patent App. 17/327,932, 2021 | 1 | 2021 |
| Megakaryocytic particles and microparticles for cell therapy and fate modification of stem and progenitor cells E Papoutsakis, CY Kao, J Jiang US Patent 10,538,738, 2020 | 1 | 2020 |
| Process optimization in enhancing end-stage iPSC-derived immune-effector cell expansion CY Kao, K Smith, J A Mills, B Marques | | 2024 |
| Megakaryocytic particles and microparticles for in vivo hematopoietic cell and gene therapies E Papoutsakis, CY Kao, J Jiang US Patent 11,820,968, 2023 | | 2023 |
| Micrornas enriched in megakaryocytic extracellular vesicles and uses thereof E Papoutsakis, CY Kao, J Jiang US Patent App. 17/770,433, 2022 | | 2022 |
| Induced pluripotent stem cells for candidate cell line selection of off-the-shelf natural killer cell therapy J Mills, CY Kao, M O’Rourke, B Morse, B Marques, G Russotti | | 2022 |
| Combinatorial effect of miR-486-5p & miR-22-3p mimics thrombopoietin’s impact on hematopoietic stem & progenitor cells CY Kao, J Jiang, ET Papoutsakis bioRxiv, 2020.02. 09.941104, 2020 | | 2020 |
| Engineering megakaryocytic microparticles for nucleic acid delivery and their biological effects to hematopoietic stem/progenitor cells CY Kao University of Delaware, 2019 | | 2019 |
| MiRNAs from Megakaryocytic Microparticles Mediating Megakaryocytic Differentiation of Hematopoietic Stem & Progenitor Cells in the Absence of Thrombopoietin CY Kao, E Papoutsakis Blood 132, 1272, 2018 | | 2018 |
